According to Novozymes's latest financial reports the company has $0.16 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.16 B | 2.15% |
2021-12-31 | $0.15 B | -26.46% |
2020-12-31 | $0.21 B | 97.41% |
2019-12-31 | $0.10 B | -3.6% |
2018-12-31 | $0.11 B | 8.09% |
2017-12-31 | $0.10 B | -9.58% |
2016-12-31 | $0.11 B | -8.22% |
2015-12-31 | $0.12 B | -69.8% |
2014-12-31 | $0.41 B | 106.54% |
2013-12-31 | $0.20 B | 96.23% |
2012-12-31 | $0.10 B | -17.43% |
2011-12-31 | $0.12 B | -57.52% |
2010-12-31 | $0.29 B | 18.55% |
2009-12-31 | $0.24 B | 32.12% |
2008-12-31 | $0.18 B | 107.97% |
2007-12-31 | $90.02 M | -24.67% |
2006-12-31 | $0.11 B | 24.76% |
2005-12-31 | $95.79 M | -15.67% |
2004-12-31 | $0.11 B | -2.09% |
2003-12-31 | $0.11 B | -20.12% |
2002-12-31 | $0.14 B |